ArticleMalaria journal2025
Preliminary analysis of the conserved Plasmodium falciparum k13 gene in Arbaminch and Mirab Abaya, Ethiopia.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundReports from East and Horn of Africa showed artemisinin resistance is threatening control efforts. The Pfkelch13 (k13) gene mutation in Plasmodium falciparum is essential for tracking artemisinin resistance, which significantly jeopardizes malaria treatment effectiveness. The objective of this study was to assess the occurrence and prevalence of k13 gene polymorphisms at selected public health facilities of Arbaminch and Mirab Abaya, Ethiopia.
methodsA cross-sectional study was conducted in Arbaminch and Mirab Abaya from May to December 2023. A total of 52 P. falciparum mono-infection samples confirmed by PCR were analysed. Sanger sequencing was used to obtain the sequences of k13 gene propeller domain, and phylogenetic analysis was performed using Molecular Evolutionary Genetic Analysis software version 11. Gene flow and differentiation were analysed with DnaSP6, while sequences from six other African countries were included from global database for haplotype network analysis using PopART 1.7.
resultsAmong the 52 participants, 28 (52.8%) were male and 24 (47.2%) were female. The median age was 19 years old with an interquartile range of 15 to 32 years. There was no polymorphism identified in the studied samples indicating high genetic conservation (pairwise similarity index = 0.982). Isolates from Mirab Abaya exhibited strong genetic homogeneity, while Arbaminch samples showed slight divergence and yet remained largely conserved. Ethiopian haplotypes contributed significantly to a dominant African haplotype, with no k13 mutations detected. Although mild genetic diversity was observed in some African countries, haplotype and nucleotide diversity were not statistically significant. A negative Fu and Li's D statistic was observed, suggesting that low-frequency mutations could be due to selective sweep in the parasite population.
conclusionThis study found no evidence of P. falciparum k13 gene mutations in isolates from Arbaminch and Mirab Abaya, indicating a high level of genetic conservation. Although minor genetic divergence was observed, particularly among Arbaminch isolates, the overall population remained genetically homogeneous. These findings highlight the continued effectiveness of artemisinin-based combination therapy in the region and emphasize the need for ongoing molecular surveillance to monitor potential resistance emergence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.